S&P 500 Consumer Discretionary Sector SEC Filings — February 22, 2026

23-02-2026

BioMarin Pharmaceutical Inc filed an 8-K on February 23, 2026, disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing information. This represents a standard earnings-related disclosure with no detailed performance data available.

23-02-2026

Artificial Intelligence Technology Solutions Inc. filed an 8-K on February 23, 2026, reporting under Item 3.03 (Material Modifications to Rights of Security Holders), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific details on the modifications, amendments, disclosures, or exhibits are provided, resulting in no quantifiable positive or negative metrics. This multi-item filing appears informational without disclosed financial or operational impacts.

23-02-2026

BullFrog AI Holdings, Inc. filed an 8-K on 2026-02-23 disclosing under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, with potential transfer of listing. Item 9.01 reports financial statements and exhibits. No quantitative financial metrics, transaction values, or further details on the delisting rationale or impacts are disclosed.

23-02-2026

Freshpet, Inc. filed an 8-K on February 23, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but provides no specific quantitative metrics, period-over-period comparisons, or guidance details in the available summary. No positive or negative financial changes are detailed.

23-02-2026

Foghorn Therapeutics Inc. filed an 8-K on 2026-02-23 disclosing officer or director changes, including departures, elections, appointments, or compensatory arrangements under Item 5.02, other events under Item 8.01, and financial statements/exhibits under Item 9.01. No specific details on the affected positions, names, reasons for changes, timing, or any quantitative metrics such as compensation amounts or share counts are explicitly stated. This is an informational filing with all key leadership change details NOT_DISCLOSED.

23-02-2026

ProCap Financial, Inc. filed an 8-K on February 23, 2026 (AccNo: 0001493152-26-007682, Size: 277 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing likely involving voluntary disclosure of material information to comply with Regulation FD, with exhibits attached. No quantitative financial metrics, transactions, guidance, or specific events are disclosed in the provided filing details.

• ·Filing date: 2026-02-23
• ·Accession Number: 0001493152-26-007682
• ·File size: 277 KB

23-02-2026

Borealis Foods Inc. filed a Form 8-K on February 23, 2026 (AccNo: 0001213900-26-019022), reporting solely under Item 8.01 Other Events. No specific details of the event, financial metrics, transactions, or quantitative data are disclosed in the provided filing information. This is a single-item voluntary disclosure with no mentioned positive or negative impacts.

23-02-2026

ALT5 Sigma Corp filed a Form 8-K on February 23, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events, any financial statements, exhibits, transactions, metrics, or impacts are disclosed. This appears to be an informational filing without quantified positive or negative developments.

23-02-2026

Fortress Biotech, Inc. filed an 8-K on February 23, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 8.01 reports other events, and Item 9.01 lists financial statements and exhibits. No specific transaction values, financial impacts, or quantitative metrics are disclosed.

23-02-2026

OFF THE HOOK YS INC. filed an 8-K on February 23, 2026 (AccNo: 0001493152-26-007690, Size: 259 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing involving a voluntary disclosure of information to comply with Regulation FD, with unspecified exhibits attached. No financial metrics, transactions, guidance, or other quantitative details are disclosed in the provided filing information.

23-02-2026

Fulton Financial Corp filed a Form 8-K on 2026-02-23 under Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details on events, transactions, financial metrics, or performance comparisons are disclosed in the provided filing information. This is a multi-item informational filing with no quantified positive or negative impacts reported.

23-02-2026

Fannie Mae filed an 8-K on February 23, 2026, reporting under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific financial metrics, transaction details, or quantitative data are disclosed in the provided filing summary. No positive or negative performance indicators are mentioned.

23-02-2026

Blue Foundry Bancorp filed an 8-K on February 23, 2026, reporting under Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details, financial metrics, transactions, or events are disclosed in the provided filing information.

23-02-2026

SOUTH PLAINS FINANCIAL, INC. filed a Form 8-K on February 23, 2026, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses unspecified other events considered material by the company along with attached exhibits, but no specific details, financial metrics, or quantitative data are provided in the summary. No positive or negative performance indicators are mentioned.

23-02-2026

Raymond James Financial Inc filed an 8-K on February 23, 2026, disclosing under Item 5.07 the submission of matters to a vote of security holders, under Item 7.01 Regulation FD disclosure, and under Item 9.01 financial statements and exhibits. No specific vote outcomes, financial metrics, transaction details, or quantitative data are provided in the filing summary. This is a multi-item informational filing with no directional financial impact disclosed.

23-02-2026

Dream Finders Homes, Inc. filed an 8-K on February 23, 2026 (AccNo: 0001628280-26-010399), reporting under Item 2.02 Results of Operations and Financial Condition, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with no detailed performance data available.

23-02-2026

WAFD INC filed an 8-K on February 23, 2026, under Item 7.01 Regulation FD Disclosure, indicating a voluntary release of material nonpublic information, and Item 9.01 Financial Statements and Exhibits, which lists attached materials (details NOT_DISCLOSED). No financial metrics, transactions, period-over-period comparisons, or specific events detailed in the filing summary. This is an informational filing with no quantified positive or negative impacts disclosed.

23-02-2026

Forward Air Corp filed an 8-K on February 23, 2026 (AccNo: 0001628280-26-010569), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This appears to be a standard earnings-related disclosure, but no specific revenue, earnings, margins, or other quantitative metrics are mentioned in the provided filing details. No positive, negative, or flat performance indicators are disclosed.

23-02-2026

FibroBiologics, Inc. filed an 8-K on February 23, 2026, reporting Item 5.07: Submission of Matters to a Vote of Security Holders. No specific details on proposals, vote outcomes, or quantitative results are disclosed in the provided filing information. This appears to be a single-item, mandatory disclosure following a shareholder meeting.

23-02-2026

INFINITY NATURAL RESOURCES, INC. filed an 8-K on 2026-02-23 disclosing entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01), alongside creation of a direct financial obligation (Item 2.03), unregistered sales of equity securities (Item 3.02), material modifications to rights of security holders (Item 3.03), departures/elections of directors/officers and compensatory arrangements (Item 5.02), and amendments to articles of incorporation or bylaws (Item 5.03). Regulation FD disclosure was also provided (Item 7.01) with financial statements and exhibits (Item 9.01). No quantitative metrics, deal values, parties involved, synergies, or performance comparisons were explicitly stated.

23-02-2026

Cleveland-Cliffs Inc. filed an 8-K on 2026-02-23 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, or quantitative impacts are disclosed. No positive or negative metrics are mentioned.

23-02-2026

Functional Brands Inc. filed an 8-K on 2026-02-23 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), and Item 9.01 (Financial Statements and Exhibits). No specific details on the agreement, personnel changes, transaction values, dollar amounts, percentages, or financial impacts are disclosed in the provided filing summary. No quantitative metrics, period-over-period comparisons, or scheduled events are mentioned.

23-02-2026

Offerpad Solutions Inc. filed an 8-K on 2026-02-23 furnishing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period comparisons are disclosed in the provided filing information. This represents a standard voluntary disclosure of quarterly or annual financial results.

23-02-2026

Braemar Hotels & Resorts Inc. filed an 8-K on February 23, 2026 (AccNo: 0001574085-26-000015, size 368 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing for voluntary disclosure of material non-public information with attached exhibits. No financial metrics, transactions, positive or negative changes, or other quantitative details are provided in the filing summary.

23-02-2026

Great Lakes Dredge & Dock Corp filed an 8-K on February 23, 2026, disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, period-over-period comparisons, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This is an informational earnings-related filing with no detailed performance data available.

23-02-2026

Genworth Financial Inc filed an 8-K on 2026-02-23 under Item 2.02 disclosing Results of Operations and Financial Condition and Item 9.01 for Financial Statements and Exhibits. This is a multi-item filing related to financial results with no specific revenue, earnings, guidance, or period-over-period metrics provided in the filing description. No positive or negative financial changes are detailed.

23-02-2026

Diversified Healthcare Trust filed an 8-K on February 23, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period comparisons were disclosed in the provided filing information. All quantitative metrics and detailed financial impacts are NOT_DISCLOSED.

23-02-2026

Brighthouse Financial, Inc. filed a Form 8-K on 2026-02-23 reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. This is a standard earnings-related disclosure. No specific revenue, earnings, balance sheet impacts, guidance, or period-over-period comparisons are disclosed in the provided filing information.

23-02-2026

UFP Industries Inc filed an 8-K on February 23, 2026, under Item 2.02 disclosing results of operations and financial condition, and Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, balance sheet details, period-over-period comparisons, guidance, or other quantitative financial metrics are mentioned in the provided filing information. This represents a standard voluntary disclosure of financial results.

23-02-2026

Martin Marietta Materials Inc. filed an 8-K on 2026-02-23 announcing the completion of an acquisition or disposition of assets under Item 2.01. The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific transaction details, financial metrics, parties involved, or quantitative impacts are disclosed.

23-02-2026

Flowers Foods Inc. filed an 8-K on 2026-02-23 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details including key position affected, individual names, appointment or resignation status, reasons for change, or financial metrics are disclosed. No positive or negative performance metrics, period-over-period comparisons, or quantitative data provided.

23-02-2026

Boston Scientific Corp filed an 8-K on February 23, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also covers Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, reason for change, timing, or any financial metrics are disclosed.

• ·AccNo: 0000885725-26-000013
• ·File size: 254 KB
• ·Sector: NOT_DISCLOSED

23-02-2026

JBT Marel Corp filed an 8-K on February 23, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing announcing financial results, but specific revenue, earnings, guidance, or other quantitative metrics are NOT_DISCLOSED in the provided filing information. No positive or negative performance details, period-over-period comparisons, or balance sheet impacts are explicitly stated.

23-02-2026

STONERIDGE INC filed an 8-K on February 23, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details such as the key position affected, names, appointment or resignation status, reasons, or timing are NOT_DISCLOSED. No quantitative metrics, financial data, scheduled events, or further context provided in the filing summary.

23-02-2026

BV Financial, Inc. filed an 8-K on February 23, 2026, reporting under Item 4.01 a change in its certifying accountant. Item 9.01 discloses financial statements and exhibits related to this change. No financial metrics, reasons for the change, or other quantitative details are provided.

23-02-2026

Reborn Coffee, Inc. filed an 8-K on 2026-02-23 disclosing under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, and under Item 5.02 departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No financial metrics, transaction values, or quantitative impacts were disclosed in the provided filing summary. This represents a multi-item filing focused on significant regulatory and leadership events.

23-02-2026

KRATOS DEFENSE & SECURITY SOLUTIONS, INC. filed an 8-K on 2026-02-23 disclosing Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, balance sheet impacts, guidance, or period-over-period comparisons are mentioned. This is a standard earnings-related disclosure with no quantified metrics provided.

23-02-2026

Village Farms International, Inc. filed an 8-K on February 23, 2026, reporting under Item 1.01 entry into a material definitive agreement, under Item 7.01 Regulation FD disclosure, and under Item 9.01 financial statements and exhibits. No specific details on the agreement, transaction size, financial metrics, positive or negative impacts, or other quantitative data are disclosed in the provided filing information. This is a multi-item filing with no period-over-period comparisons or named entities beyond the filer mentioned.

23-02-2026

Better Home & Finance Holding Co filed an 8-K on February 23, 2026, reporting under Item 1.01 entry into a material definitive agreement. Item 9.01 provides for financial statements and exhibits. No specific details including transaction value, parties, terms, financial impacts, or strategic context are disclosed.

23-02-2026

Willow Lane Acquisition Corp. II filed an 8-K on 2026-02-23 disclosing other events under Item 8.01 and financial statements and exhibits under Item 9.01 in connection with a merger/acquisition event. No specific deal structure, parties involved beyond the filer, valuation, financial terms, or quantitative metrics are disclosed in the filing summary provided. No positive or negative performance metrics are mentioned.

23-02-2026

HA Sustainable Infrastructure Capital, Inc. filed an 8-K on 2026-02-23 reporting under Item 1.01 entry into a material definitive agreement. Item 9.01 discloses financial statements and exhibits. No specific details on the agreement, transaction value, parties, financial impacts, or other metrics are provided.

23-02-2026

Palomar Holdings, Inc. filed an 8-K on February 23, 2026, reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, transaction details, or performance comparisons are disclosed in the filing summary. The filing size is 10 MB with AccNo 0001193125-26-064398.

23-02-2026

TCW Strategic Income Fund Inc filed an 8-K on February 23, 2026, reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 8.01 Other Events. No specific details regarding the nature of the agreement, transaction size, financial impacts, or other quantitative metrics are disclosed in the provided filing summary. This represents a multi-item mandatory disclosure with no period-over-period comparisons or named entities beyond the filer mentioned.

23-02-2026

Lument Finance Trust, Inc. filed an 8-K on February 23, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement. Item 9.01 discloses financial statements and exhibits. No specific transaction details, dollar values, financial impacts, or other metrics are provided.